PACC5Biomarker1 paperHumans1LatestNov 2025: 0Dec 2025: 13Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 1Oct 2026: 016Human Brain MappingHumans·21 SepDTI-ALPS as a Biomarker of Small Vessel Disease Progression and Amyloid-β in Normal Aging: A 3-Year Longitudinal StudyBiomarkersNeurologyHumans·31 AugAssociation Between Alzheimer Pathology, Sleep, and Cognition in Patients With Late-Onset Unexplained EpilepsyBiomarkersAAIC 2025 AbstractHumans·9 JanLower resting‐state phasic locus coeruleus activity is associated with cortical tau accumulation and cognitive decline in preclinical Alzheimer's diseaseMechanismsAAIC 2025 AbstractHumans·26 DecBaseline amyloid spatial extent in combination with tau burden captures cognitive decline, measured digital clock drawing test and PACC5, in preclinical Alzheimer's diseaseBiomarkersAAIC 2025 AbstractHumans·26 DecDoes Mood Matter: The impact of affective symptoms on the Digital Clock Test scores, a portable and sensitive screen for cognitive impairmentBiomarkersAAIC 2025 AbstractHumans·26 DecThe Latin American Spanish Preclinical Alzheimer's Cognitive Composite (LAS‐PACC5): Adapted for Spanish‐Speaking Latino PopulationsBiomarkersAAIC 2025 AbstractHumans·26 DecAssociations of cognitive debt and cognitive reserve with mixed brain pathology and cognitionPopulationsAAIC 2025 AbstractHumans·25 DecPredictors of Cognitive Decline in Individuals with Subjective Cognitive Decline of the DELCODE Study CohortPopulationsAAIC 2025 AbstractHumans·25 DecDiscrimination tasks increase the value of plasma p ‐tau217 to predict presymptomatic Alzheimer's diseaseBiomarkersAAIC 2025 AbstractHumans·25 DecSensitivity of cognitive composite scores to amyloid accumulation in emergent Alzheimer's diseaseBiomarkers
Human Brain MappingHumans·21 SepDTI-ALPS as a Biomarker of Small Vessel Disease Progression and Amyloid-β in Normal Aging: A 3-Year Longitudinal StudyBiomarkers
NeurologyHumans·31 AugAssociation Between Alzheimer Pathology, Sleep, and Cognition in Patients With Late-Onset Unexplained EpilepsyBiomarkers
AAIC 2025 AbstractHumans·9 JanLower resting‐state phasic locus coeruleus activity is associated with cortical tau accumulation and cognitive decline in preclinical Alzheimer's diseaseMechanisms
AAIC 2025 AbstractHumans·26 DecBaseline amyloid spatial extent in combination with tau burden captures cognitive decline, measured digital clock drawing test and PACC5, in preclinical Alzheimer's diseaseBiomarkers
AAIC 2025 AbstractHumans·26 DecDoes Mood Matter: The impact of affective symptoms on the Digital Clock Test scores, a portable and sensitive screen for cognitive impairmentBiomarkers
AAIC 2025 AbstractHumans·26 DecThe Latin American Spanish Preclinical Alzheimer's Cognitive Composite (LAS‐PACC5): Adapted for Spanish‐Speaking Latino PopulationsBiomarkers
AAIC 2025 AbstractHumans·26 DecAssociations of cognitive debt and cognitive reserve with mixed brain pathology and cognitionPopulations
AAIC 2025 AbstractHumans·25 DecPredictors of Cognitive Decline in Individuals with Subjective Cognitive Decline of the DELCODE Study CohortPopulations
AAIC 2025 AbstractHumans·25 DecDiscrimination tasks increase the value of plasma p ‐tau217 to predict presymptomatic Alzheimer's diseaseBiomarkers
AAIC 2025 AbstractHumans·25 DecSensitivity of cognitive composite scores to amyloid accumulation in emergent Alzheimer's diseaseBiomarkers